Literature DB >> 19958086

Pharmacogenomics of methotrexate: moving towards individualized therapy.

Jacob Nersting, Kjeld Schmiegelow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19958086     DOI： 10.2217/pgs.09.148

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  3 in total

1.  Challenges in implementing individualized medicine illustrated by antimetabolite therapy of childhood acute lymphoblastic leukemia.

Authors:  Jacob Nersting; Louise Borst; Kjeld Schmiegelow
Journal:  Clin Proteomics       Date:  2011-06-03       Impact factor: 3.988

2.  Using subcutaneous methotrexate to prolong duration of methotrexate therapy in rheumatoid arthritis.

Authors:  Emily Harris; Bernard Ng
Journal:  Eur J Rheumatol       Date:  2018-02-13

3.  Effect of the Polymorphism of Folylpolyglutamate Synthetase on Treatment of High-Dose Methotrexate in Pediatric Patients with Acute Lymphocytic Leukemia.

Authors:  Zhen Huang; Hong-Fei Tong; Yuan Li; Jiang-Chao Qian; Ju-Xiang Wang; Zhe Wang; Ji-Chen Ruan
Journal:  Med Sci Monit       Date:  2016-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.